MedPath

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

THE BRIGHAM AND WOMEN'S HOSPITAL, INC. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel

Phase 1
Not yet recruiting
Conditions
Infectious Disease
Drug Effect
Clinical Infection
Interventions
First Posted Date
2023-04-03
Last Posted Date
2023-04-03
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
21
Registration Number
NCT05796362

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol

Active, not recruiting
Conditions
Hypertension
Interventions
Drug: Atenolol, Bisoprolol or Sotalol
First Posted Date
2023-04-03
Last Posted Date
2023-07-19
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
817337
Registration Number
NCT05794997
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.

Not Applicable
Terminated
Conditions
Spleen Lesion
Bleeding Disorder
Liver Diseases
Kidney Diseases
Interventions
Device: RF track cautery during percutaneous organ biopsy
First Posted Date
2023-03-29
Last Posted Date
2023-08-01
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
4
Registration Number
NCT05790109
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Developing an HIV Disclosure Intervention for Men in Uganda

Not Applicable
Not yet recruiting
Conditions
Sexually Transmitted Infections (Not HIV or Hepatitis)
HIV Infections
Interventions
Behavioral: HIV disclosure intervention
First Posted Date
2023-03-16
Last Posted Date
2023-03-17
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
70
Registration Number
NCT05771519
Locations
🇺🇬

Mbarara University of Science and Technology, Mbarara, Uganda

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Active, not recruiting
Conditions
Diabetes
Interventions
Drug: DPP-4 inhibitor
First Posted Date
2023-03-15
Last Posted Date
2023-07-19
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
742670
Registration Number
NCT05768945
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults

Not Applicable
Completed
Conditions
Cognitive Decline
Nutrition, Healthy
Brain Injuries
Interventions
Dietary Supplement: Blueberry powder
Other: Controlled and matched powder
First Posted Date
2023-03-13
Last Posted Date
2024-10-04
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
67
Registration Number
NCT05764824
Locations
🇺🇸

Mass General Brigham, Boston, Massachusetts, United States

SCI-Lynx: A Mobile Platform for Physical Activity Social Support for People With SCI Pilot Study

Not Applicable
Recruiting
Conditions
Spinal Cord Injuries
Interventions
Behavioral: SCI-Lynx Mobile Application
First Posted Date
2023-03-10
Last Posted Date
2023-06-22
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
50
Registration Number
NCT05764135
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

NAD Augmentation in Diabetes Kidney Disease

Phase 2
Recruiting
Conditions
Type2diabetes
Diabetic Kidney Disease
Interventions
Drug: Investigational Product - MIB 626
Drug: Placebo
First Posted Date
2023-03-08
Last Posted Date
2023-04-25
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
140
Registration Number
NCT05759468
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care

Not Applicable
Recruiting
Conditions
Insomnia
Interventions
Behavioral: Tele-Cognitive-Behavioral Therapy for Insomnia
Behavioral: Tele-Brief Behavioral Treatment for Insomnia
First Posted Date
2023-03-08
Last Posted Date
2024-04-04
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
350
Registration Number
NCT05759065
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Cesarean 123 Trial: Randomized Trial Comparing Single, Double and Triple Layer Uterine Closures During Cesarean Delivery

Not Applicable
Not yet recruiting
Conditions
Pregnancy Related
Interventions
Procedure: Uterine layers closed
Device: Suture Type
Procedure: Endometrium
First Posted Date
2023-03-01
Last Posted Date
2023-03-02
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
120
Registration Number
NCT05750394
© Copyright 2025. All Rights Reserved by MedPath